Literature DB >> 6422973

Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.

C G Semple, J A Thomson, G H Beastall, A R Lorimer.   

Abstract

Calcium ions seem to be essential for the release of many hormones. The calcium antagonist verapamil which is used as an anti-arrhythmic and anti-anginal agent has an inhibitory effect on the release of follicle stimulating hormone (FSH), luteinising hormone (LH), and thyrotrophin stimulating hormone (TSH) when given as an intravenous infusion to normal volunteers. As verapamil is usually given orally we studied pituitary-testicular and pituitary-thyroid function before and after completing a 4-week course of oral verapamil. The oral preparation did not have any significant effect on the endocrine parameters studied.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422973      PMCID: PMC1463315          DOI: 10.1111/j.1365-2125.1984.tb02336.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Purified growth hormone releasing factor increases 45 Ca uptake into pituitary cells.

Authors:  J V Milligan; J Kraicer; C P Fawcett; P Illner
Journal:  Can J Physiol Pharmacol       Date:  1972-06       Impact factor: 2.273

2.  Presence of calcium ions as a requisite for the in vitro stimulation of TSH-release by hypothalamic TRF.

Authors:  W Vale; R Burgus; R Guillemin
Journal:  Experientia       Date:  1967-10-15

3.  Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy.

Authors:  B G Woodcock; R Hopf; M Kaltenbach
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jan-Feb       Impact factor: 3.105

4.  Verapamil-induced hyperprolactinemia and galactorrhea.

Authors:  L E Gluskin; B Strasberg; J H Shah
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

5.  Hyperglycaemic effect of nifedipine.

Authors:  S Charles; J M Ketelslegers; M Buysschaert; A E Lambert
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

6.  Effects of nifedipine on prolactin, growth hormone, and luteinizing hormone release by rat anterior pituitary in vitro.

Authors:  J Takahara; S Yunoki; Y Yamane; J Yamauchi; W Yakushiji; N Kageyama; K Fujino; T Ofuji
Journal:  Proc Soc Exp Biol Med       Date:  1979-10

7.  In vitro response of the rat pituitary to gonadotrophin-releasing factors and to ions.

Authors:  K Wakabayashi; I A Kamberi; S M McCann
Journal:  Endocrinology       Date:  1969-12       Impact factor: 4.736

8.  Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.

Authors:  L De Marinis; A Barbarino
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

9.  Steroidogenic action of calcium ions in isolated adrenocortical cells.

Authors:  E J Podesta; A Milani; H Steffen; R Neher
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

10.  Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone- and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects.

Authors:  A Barbarino; L De Marinis
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

View more
  2 in total

1.  Nifedipine and endocrine status in diabetic patients.

Authors:  E Abadie; C Gauville; C Brisson
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

2.  Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism.

Authors:  Lijuan Yang; Xiuqin Sun; Yi Zhao; Hong Tao
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.